Hematology
| 3 min read
Roswell Park researchers publish two studies on progress against the disease
| 4 min read
Trial indicates that the process shows benefit for gliobastoma patients
| 10+ min read
Glioblastoma remains a difficult cancer to treat, but the brain malignancy is seeing increasing attention in R&D
| 4 min read
Kamada’s Phase 2 proof-of-concept trial shows prevention of lung transplant rejection for one year
| 2 min read
TRACON announces results from ongoing Phase 1b/2 trial in hepatocellular carcinoma
| 2 min read
Vect-Horus and RadioMedix announce the signing of a letter of intent to co-develop a radio-theranostic agent for glioblastoma
| 3 min read
The company is making a $4.8-billion bid to acquire Spark Therapeutics
| 2 min read
Sysmex Inostics’ OncoBEAM demonstrates clinical validity and superior performance versus pan-cancer NGS for blood-based mutation detection for hepatocellular carcinoma
| 5 min read
Among other benefits, addition of Loxo will broaden scope of Lilly’s oncology portfolio into precision medicines
| 3 min read
Novel approach appears to circumvent inhibitors to factor VIII in early clinical studies
| 4 min read
Collaboration provides Q BioMed with formulation and preclinical expertise to progress QBM-001 for pediatric nonverbal disorder in autism
